Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Rhea-AI Summary
Precision Optics (Nasdaq: POCI) will participate in the virtual Lytham Partners Spring 2026 Investor Conference on May 28, 2026. The Company will host a webcast presentation and conduct one-on-one investor meetings.
The webcast is scheduled for 1:00 p.m. ET and will be available for replay after the event.
Positive
- None.
Negative
- None.
News Market Reaction – POCI
In the May 19 session, POCI declined 1.18%, reflecting a mild negative market reaction. Argus tracked a peak move of +7.0% during that session. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility. Trading volume was above average at 1.5x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 13 | Earnings results | Positive | +3.9% | Record Q3 revenue, improved margins, raised FY2026 revenue and EBITDA guidance. |
| May 06 | Earnings call setup | Neutral | +0.8% | Scheduled Q3 FY2026 earnings call and webcast details for investors. |
| May 05 | New production order | Positive | +8.8% | Received $3.5M follow-on production order for single-use ophthalmic endoscope. |
| Mar 27 | Equity offering priced | Negative | -0.5% | Priced upsized $10M underwritten public offering of common stock at $3.60. |
| Mar 26 | Offering proposed | Negative | -0.5% | Announced proposed underwritten public offering of common stock under S-3 shelf. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has generally aligned with price reactions: operational wins and strong earnings saw positive moves, while equity offerings coincided with modest declines.
Over the past few months, Precision Optics reported record Q3 FY2026 revenue of $8.7 million and raised full‑year guidance on May 13, 2026, which coincided with a positive price reaction. Earlier in May it announced a $3.5 million follow‑on ophthalmic production order that also aligned with a strong gain. In late March, the company completed an upsized $10 million equity offering off its shelf registration, which saw a small negative reaction consistent with typical dilution concerns. Today’s conference participation fits into this ongoing investor‑outreach pattern.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LITTLETON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.
Company Webcast
The webcast presentation will take place at 1:00 p.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/Ka2bMmgyojv. The webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/spring2026invreg/.
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.
Company Contact:
PRECISION OPTICS CORPORATION
550 King Street, Building A, Suite 100
Littleton, MA 01460
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com
